Background Venous thromboembolism (VTE) is a frequent complication of COVID-19, so
that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with …

Background: The coronavirus disease 2019 (COVID-19) is a newly recognized illness that
has spread rapidly all over the world. Severe hypoxemic respiratory failure from COVID-19 …

BACKGROUND Emerging evidence shows that severe COVID-19 can be complicated by a
significant coagulopathy, that likely manifests in the form of both microthrombosis and …

Background A possible association between COVID-19 infection and thrombosis, either as a
direct consequence of the virus or as a complication of inflammation, is emerging in the …

Background Venous thromboembolism (VTE) is a potentially fatal complication of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and thromboprophylaxis …

Background The incidence of venous thromboembolic events (VTE) in patients with COVID-
19 is generally high but varies markedly. However, the relationship between anticoagulation …

Venous thromboembolism (VTE) has emerged as an important issue in patients with COVID-
19. The purpose of this study is to identify the incidence of VTE and mortality in COVID-19 …

Although COVID-19 has been reported to be associated with high rates of venous
thromboembolism (VTE), the risk of VTE and bleeding after hospitalization for COVID-19 …

Background The reported incidence of venous thromboembolism (VTE) in COVID-19
patients varies widely depending on patient populations sampled and has been …

Aim An increased risk of venous thromboembolism (VTE) in patients with COVID-19
pneumonia admitted to intensive care unit (ICU) has been reported. Whether COVID-19 …